Psagot Value Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
ACA
Psagot Value Holdings's XBI Position: Q2 2024 in Review
Psagot Value Holdings sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 20 shares — an estimated $2K sold.
Psagot Value Holdings first reported a position in XBI in Q2 2013 and held it in 24 quarters. The position peaked at $23.5M in Q3 2013. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.
- Psagot Value Holdings reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
- Psagot Value Holdings sold 20 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $2K.
- Psagot Value Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 24 quarters.
- Psagot Value Holdings's State Street SPDR S&P Biotech ETF position peaked at $23.5M in Q3 2013.
- 761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.
Based on Psagot Value Holdings's 13F filing for Q2 2024.